These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 2448794)
1. Expression of soluble, enzymatically active, human immunodeficiency virus reverse transcriptase in Escherichia coli and analysis of mutants. Hizi A; McGill C; Hughes SH Proc Natl Acad Sci U S A; 1988 Feb; 85(4):1218-22. PubMed ID: 2448794 [TBL] [Abstract][Full Text] [Related]
2. Expression of reverse transcriptase from feline immunodeficiency virus in Escherichia coli. North TW; Hansen GL; Zhu Y; Griffin JA; Shih CK Antimicrob Agents Chemother; 1994 Feb; 38(2):388-91. PubMed ID: 7514859 [TBL] [Abstract][Full Text] [Related]
3. Expression and mutational analysis of the reverse transcriptase of the lentivirus equine infectious anemia virus. Shaharabany M; Rice NR; Hizi A Biochem Biophys Res Commun; 1993 Oct; 196(2):914-20. PubMed ID: 7694581 [TBL] [Abstract][Full Text] [Related]
4. A single 66-kilodalton polypeptide processed from the human immunodeficiency virus type 2 pol polyprotein in Escherichia coli displays reverse transcriptase activity. Le Grice SF; Zehnle R; Mous J J Virol; 1988 Jul; 62(7):2525-9. PubMed ID: 2453682 [TBL] [Abstract][Full Text] [Related]
5. Effects of small insertions on the RNA-dependent DNA polymerase activity of HIV-1 reverse transcriptase. Hizi A; Barber A; Hughes SH Virology; 1989 May; 170(1):326-9. PubMed ID: 2470195 [TBL] [Abstract][Full Text] [Related]
6. Processing protease and reverse transcriptase from human immunodeficiency virus type I polyprotein in Escherichia coli. Mous J; Heimer EP; Le Grice SF J Virol; 1988 Apr; 62(4):1433-6. PubMed ID: 2450209 [TBL] [Abstract][Full Text] [Related]
7. Expression of polypeptides of human immunodeficiency virus-1 reverse transcriptase in Escherichia coli. Becerra SP; Kumar A; Wilson SH Protein Expr Purif; 1993 Jun; 4(3):187-99. PubMed ID: 7686063 [TBL] [Abstract][Full Text] [Related]
8. Structural requirements for bacterial expression of stable, enzymatically active fusion proteins containing the human immunodeficiency virus reverse transcriptase. Tanese N; Prasad VR; Goff SP DNA; 1988; 7(6):407-16. PubMed ID: 2462482 [TBL] [Abstract][Full Text] [Related]
9. Infectious potential of human immunodeficiency virus type 1 reverse transcriptase mutants with altered inhibitor sensitivity. Larder BA; Kemp SD; Purifoy DJ Proc Natl Acad Sci U S A; 1989 Jul; 86(13):4803-7. PubMed ID: 2472634 [TBL] [Abstract][Full Text] [Related]
10. A screen in Escherichia coli for nucleoside analogs that target human immunodeficiency virus (HIV) reverse transcriptase: coexpression of HIV reverse transcriptase and herpes simplex virus thymidine kinase. Kim B; Loeb LA J Virol; 1995 Oct; 69(10):6563-6. PubMed ID: 7545249 [TBL] [Abstract][Full Text] [Related]
11. Mutational analysis of the DNA polymerase and ribonuclease H activities of human immunodeficiency virus type 2 reverse transcriptase expressed in Escherichia coli. Hizi A; Tal R; Hughes SH Virology; 1991 Jan; 180(1):339-46. PubMed ID: 1701948 [TBL] [Abstract][Full Text] [Related]
12. Molecular characterization of a polymerase mutant human immunodeficiency virus. Gendelman HE; Theodore TS; Willey R; McCoy J; Adachi A; Mervis RJ; Venkatesan S; Martin MA Virology; 1987 Oct; 160(2):323-9. PubMed ID: 2444031 [TBL] [Abstract][Full Text] [Related]
13. Expression of an active form of recombinant Ty1 reverse transcriptase in Escherichia coli: a fusion protein containing the C-terminal region of the Ty1 integrase linked to the reverse transcriptase-RNase H domain exhibits polymerase and RNase H activities. Wilhelm M; Boutabout M; Wilhelm FX Biochem J; 2000 Jun; 348 Pt 2(Pt 2):337-42. PubMed ID: 10816427 [TBL] [Abstract][Full Text] [Related]
14. Overproduction of human immunodeficiency virus type I reverse transcriptase in Escherichia coli and purification of the enzyme. Saitoh A; Iwasaki H; Nakata A; Adachi A; Shinagawa H Microbiol Immunol; 1990; 34(6):509-21. PubMed ID: 1699113 [TBL] [Abstract][Full Text] [Related]
15. Purification and biochemical characterization of recombinant simian immunodeficiency virus protease and comparison to human immunodeficiency virus type 1 protease. Grant SK; Deckman IC; Minnich MD; Culp J; Franklin S; Dreyer GB; Tomaszek TA; Debouck C; Meek TD Biochemistry; 1991 Aug; 30(34):8424-34. PubMed ID: 1883829 [TBL] [Abstract][Full Text] [Related]
16. [Reverse transcriptase of the human immunodeficiency virus: cloning, expression in Escherichia coli, purification of the enzyme, and production of monoclonal antibodies]. Rechinskiĭ VO; Barbashov SF; Degtiarev IL; Vorob'ev SM; Liakhov DL; Kostiuk DA; Starov AI; Matsevich GR; Kochetkov SN Mol Biol (Mosk); 1991; 25(5):1248-57. PubMed ID: 1721676 [TBL] [Abstract][Full Text] [Related]
17. Analysis of mutagenesis induced by expression of retroviral reverse transcriptase in Escherichia coli. Ennis DG; Crouch RJ Biochimie; 1993; 75(1-2):101-5. PubMed ID: 7684931 [TBL] [Abstract][Full Text] [Related]
18. Construction of an enzymatically active ribonuclease H domain of human immunodeficiency virus type 1 reverse transcriptase. Stahl SJ; Kaufman JD; Vikić-Topić S; Crouch RJ; Wingfield PT Protein Eng; 1994 Sep; 7(9):1103-8. PubMed ID: 7530360 [TBL] [Abstract][Full Text] [Related]
19. Engineering of the human-immunodeficiency-virus-type-1 (HIV-1) reverse transcriptase gene to prevent dimerization of the expressed chimaeric protein: purification and characterization of a monomeric HIV-1 reverse transcriptase. Sharma SK; Basu A; Fan N; Evans DB Biotechnol Appl Biochem; 1994 Apr; 19(2):155-67. PubMed ID: 7514879 [TBL] [Abstract][Full Text] [Related]
20. Structural characterization of HIV reverse transcriptase: a target for the design of specific virus inhibitors. Tisdale M; Larder BA; Lowe DM; Stammers DK; Purifoy DJ; Ertl P; Bradley C; Kemp S; Darby GK; Powell KL J Antimicrob Chemother; 1989 Jan; 23 Suppl A():47-54. PubMed ID: 2469675 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]